System Transmission

Top Signal

100#1 JOB

Activity

2177Ripe

+933 today

System

Live1m

Terminal Asset View

stockNASDAQ

KYTX

$8.95+2.05%

Kyverna Therapeutics Inc

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

80Ripe

Live Analysis Active

Company Mission

Kyverna Therapeutics creates cell-based treatments for autoimmune diseases like lupus and multiple sclerosis. These treatments use modified immune cells to help patients whose immune systems attack their own bodies. The company makes money through research funding and hopes to earn revenue from selling approved treatments in the future.

KYT

Industry Context

The biotech industry focuses on developing medical treatments using biological systems. Companies in this space often work on treatments for diseases that don't have good existing options. Autoimmune diseases affect millions of people, creating significant demand for new therapies.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

89Matrix

Market Momentum

55.6— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

1.0x— Normal Volume

Today's Change

2.05%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing KYTX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:31 PM UTC

As-of 03-15-2026 14:15 UTC

Develops cell therapies that treat autoimmune diseases and makes money by selling these treatments to hospitals and clinics.

Weekly price volatility is tightening near recent levels, suggesting a potential breakout move is building.

Biotech sector showing interest in autoimmune treatments, which could benefit companies with promising clinical data.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...